Reduced DNA repair in cultured melanocytes and nevus cells from a patient with xeroderma pigmentosum
- PMID: 2913963
Reduced DNA repair in cultured melanocytes and nevus cells from a patient with xeroderma pigmentosum
Abstract
Patients with xeroderma pigmentosum (XP) have more than a 1000-fold increased risk of cutaneous melanoma. To determine if the XP DNA repair defect is present in cutaneous pigmentary cells, nevus cells and melanocytes from four large, pigmented nevi were cultured from a 12-year-old girl with XP. Cultured melanocytes showed dendritic morphologic features, contained mature melanosomes, and reacted with monoclonal antibody to tyrosinase. Nevus cells were spindle shaped and expressed nevus cell-associated antigens. Melanocytes, nevus cells, and dermal fibroblasts from the patient with XP all had a similar reduction in DNA repair: unscheduled DNA synthesis was 30% to 50% of that in normal fibroblasts following a 30 J/m2 ultraviolet dose. After a 6 J/m2 ultraviolet dose, the proliferative ability of XP nevus cells and fibroblasts was reduced to 10% of that of normal fibroblasts. This study indicates that cultured melanocytes and nevus cells express the characteristic XP DNA repair defect.
Similar articles
-
Defective DNA repair in cultured melanocytes from xeroderma pigmentosum patients.J Dermatol. 1990 Aug;17(8):465-72. doi: 10.1111/j.1346-8138.1990.tb01677.x. J Dermatol. 1990. PMID: 2229649
-
Revealing the UV response of melanocytes in xeroderma pigmentosum group A using patient-derived induced pluripotent stem cells.J Dermatol Sci. 2024 Sep;115(3):111-120. doi: 10.1016/j.jdermsci.2024.06.004. Epub 2024 Jun 22. J Dermatol Sci. 2024. PMID: 39033075
-
DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and cockayne syndrome resemble xeroderma pigmentosum cells.J Invest Dermatol. 1996 Oct;107(4):647-53. doi: 10.1111/1523-1747.ep12584287. J Invest Dermatol. 1996. PMID: 8823375
-
Replication of damaged DNA: molecular defect in xeroderma pigmentosum variant cells.Mutat Res. 1999 Oct 22;435(2):111-9. doi: 10.1016/s0921-8777(99)00047-6. Mutat Res. 1999. PMID: 10556591 Review.
-
Xeroderma pigmentosum: from genetics to hopes and realities of cutaneous gene therapy.Expert Opin Biol Ther. 2004 Feb;4(2):169-79. doi: 10.1517/14712598.4.2.169. Expert Opin Biol Ther. 2004. PMID: 14998776 Review.
Cited by
-
Different germline variants in the XPA gene are associated with severe, intermediate, or mild neurodegeneration in xeroderma pigmentosum patients.PLoS Genet. 2024 Dec 2;20(12):e1011265. doi: 10.1371/journal.pgen.1011265. eCollection 2024 Dec. PLoS Genet. 2024. PMID: 39621777 Free PMC article.
-
Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.J Med Genet. 2011 Mar;48(3):168-76. doi: 10.1136/jmg.2010.083022. Epub 2010 Nov 19. J Med Genet. 2011. PMID: 21097776 Free PMC article.
-
Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression.J Invest Dermatol. 2008 Jan;128(1):175-87. doi: 10.1038/sj.jid.5700935. Epub 2007 Jun 28. J Invest Dermatol. 2008. PMID: 17597816 Free PMC article.
-
Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene.Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8658-63. doi: 10.1073/pnas.94.16.8658. Proc Natl Acad Sci U S A. 1997. PMID: 9238033 Free PMC article.
-
Forty years of research on xeroderma pigmentosum at the US National Institutes of Health.Photochem Photobiol. 2015 Mar-Apr;91(2):452-9. doi: 10.1111/php.12345. Epub 2015 Jan 8. Photochem Photobiol. 2015. PMID: 25220021 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials